Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies [PMID: 33417153] Laboratory literature summary: Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Garczorz W, Gallego-Colon E, Kosowska A, Kych-Ratuszny A, Woniak M, Marcol W, Niesner KJ, Francuz T
Patients who have undergone bariatric surgery may be at increased risk of dehydration and electrolyte disturbances when experiencing GLP-1 receptor agonist-related gastrointestinal side effects, particularly if vomiting is severe
It is worth noting that the current UK Summary of Product Characteristics (SmPC) for Wegovy does not list suicidality as an adverse reaction, although regulatory authorities continue to monitor this area closely
